This dual action offers a unique approach compared to single-action treatments like Semaglutide
It is being studied for weight management and prescribed by US-licensed physicians where appropriate
Meanwhile, long-term use also disrupts intestinal microbiota (bacteria and fungi), risks multidrug-resistant fungi, and carries hepatotoxic or even fatal side effects 169,170
Schnabl B
Ongoing research highlights the significant clinical potential of incretin-based therapies, especially in emerging areas such as central nervous system disorders, substance use, and post-transplant care
Wegovy is a brand that manufactures Semaglutide in Pens just like Ozempic but it comes if different dosage formats than Ozempic Wegovy (semaglutide) is available in Mexico in several dose pens such as 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg [4]